Technology | Guidewires | October 21, 2019

FDA Approves Coronary ViperWire Advance With Flex Tip

U.S. approval of nitinol atherectomy guide wire expands Cardiovascular Systems’ portfolio of products targeting complex coronary disease

FDA Approves Coronary ViperWire Advance With Flex Tip

October 21, 2019 — Cardiovascular Systems Inc. recently announced U.S. Food and Drug Administration (FDA) premarket approval (PMA) of the new ViperWire Advance Coronary Guide Wire with Flex Tip (ViperWire Advance with Flex Tip).

ViperWire Advance with Flex Tip is the latest advancement to CSI’s coronary Diamondback 360 orbital atherectomy system. Diamondback treats calcific coronary artery disease by both safely reducing superficial lesions and creating fractures of deep calcium, facilitating stent delivery, expansion and wall apposition for low restenosis rates.

ViperWire Advance with Flex Tip offers a combination of flexible nitinol core with a shapeable floppy tip to help physicians navigate in complex anatomy. In addition, the flexible nitinol body can reduce wire bias during atherectomy. Together, these benefits can enable physicians to access and effectively treat challenging lesions.

“We are treating increasingly complex coronary disease in older patients with more comorbid conditions,” commented Richard Shlofmitz, M.D., chairman, Department of Cardiology at St. Francis Hospital in Roslyn, N.Y. “Many of these patients have calcified coronary lesions which can lead to poor outcomes. Enhancing trackability and performance of atherectomy with ViperWire Advance with Flex Tip will help me more effectively treat calcific disease.”

Mitchell Krucoff, M.D., professor of medicine at Duke University Medical Center in Durham, N.C., said, “With a shapeable floppy tip and flexible nitinol body, ViperWire Advance with Flex Tip will help physicians efficiently gain lesion access in complex anatomy and reduce wire bias during treatment. This can be a game changer for patient care.”

For more information: www.csi360.com

Related Guidewire Content

Recent Advances in Interventional Guidewire Technology

FDA Issues Final Guidances on Guidewires, Intravascular Catheters and Delivery Systems

VIDEO: Basics of Interventional Guidewire Design and Function

Related Content

News | Guidewires

April 12, 2022 — Transit Scientific announced the FDA clearance of its XO Cross Support Catheter Platform to include ...

Home April 12, 2022
Home
News | Guidewires

October 11, 2019 — The U.S. Food and Drug Administration (FDA) issued two final guidances for the performance testing ...

Home October 11, 2019
Home
Feature | Guidewires | Dave Fornell, Editor

Guidewire engineering has become more advanced over the past decade as interventional cardiologists have advanced their ...

Home August 02, 2019
Home
Technology | Guidewires

May 21, 2019 – Medtronic plc announced its entrance into the guide extension catheter market with the global launch of ...

Home May 21, 2019
Home
News | Guidewires

April 10, 2019 — According to a new research study, straight tip guidewires, with a current share of more than a third ...

Home April 10, 2019
Home
News | Guidewires

June 14, 2018 — The U.S. Food and Drug Administration (FDA) released the following two draft guidance documents ...

Home June 14, 2018
Home
News | Guidewires

May 30, 2017 — A Canadian cardiologist has published a report in the journal Eurointervention describing how he used a ...

Home May 30, 2017
Home
Technology | Guidewires

March 20, 2017 — Teleflex Inc. recently announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U ...

Home March 20, 2017
Home
Videos | Guidewires

A discussion with guidewire expert Dimitri Karmpaliotis, M.D., Ph.D., FACC, about the basics of interventional guidewire ...

Home November 18, 2016
Home
Feature | Guidewires | Dave Fornell

While guidewires are a key tool used by all interventionalists in the cath lab, most operators do not have a deep ...

Home October 12, 2016
Home
Subscribe Now